China's second-largest life insurer also upped its investments in a selective number of stocks, according to its latest interim results.
By enlarging their investment scopes, the regulator is also paving the way for them to expand their businesses in China
Institutional investors – most notably insurance firms – in China are increasingly looking to step up allocations to private equity, with the encouragement of regulators.
But they may be less sure about the investments they will be able to make after the regulator updated the asset-liability management framework last week.
Another long-standing staffer has left the Hong Kong-based fund house after a series of senior departures and reshuffles, and is understood to be joining a rival.
The world's biggest fund house is making changes to its management and sales setup in Taiwan after a sharp fall in its assets under management there since end-2017.